Emily Behar

799 total citations
18 papers, 610 citations indexed

About

Emily Behar is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Anesthesiology and Pain Medicine. According to data from OpenAlex, Emily Behar has authored 18 papers receiving a total of 610 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Public Health, Environmental and Occupational Health, 9 papers in Epidemiology and 7 papers in Anesthesiology and Pain Medicine. Recurrent topics in Emily Behar's work include Opioid Use Disorder Treatment (16 papers), Pain Management and Opioid Use (7 papers) and Substance Abuse Treatment and Outcomes (6 papers). Emily Behar is often cited by papers focused on Opioid Use Disorder Treatment (16 papers), Pain Management and Opioid Use (7 papers) and Substance Abuse Treatment and Outcomes (6 papers). Emily Behar collaborates with scholars based in United States. Emily Behar's co-authors include Phillip O. Coffin, Glenn‐Milo Santos, Christopher Rowe, Eric Vittinghoff, Diana Coffa, Caitlin Turner, Eliza Wheeler, Tim Matheson, Sheigla Murphy and Jamie Chang and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and Journal of General Internal Medicine.

In The Last Decade

Emily Behar

18 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily Behar United States 13 535 303 195 143 117 18 610
Michael A. Yokell United States 10 583 1.1× 386 1.3× 113 0.6× 199 1.4× 138 1.2× 15 735
Angela Clark United States 6 423 0.8× 275 0.9× 97 0.5× 106 0.7× 118 1.0× 16 491
Meelee Kim United States 7 470 0.9× 283 0.9× 117 0.6× 60 0.4× 166 1.4× 9 564
Amy Sorensen-Alawad United States 6 874 1.6× 613 2.0× 204 1.0× 235 1.6× 245 2.1× 8 988
Jeffrey McPheeters United States 8 556 1.0× 443 1.5× 69 0.4× 60 0.4× 190 1.6× 21 700
Diana Coffa United States 10 278 0.5× 185 0.6× 110 0.6× 53 0.4× 70 0.6× 13 397
Payel Roy United States 10 460 0.9× 354 1.2× 98 0.5× 41 0.3× 116 1.0× 23 564
Brodie Clark Australia 4 423 0.8× 314 1.0× 89 0.5× 47 0.3× 114 1.0× 4 532
Martha J. Wunsch United States 8 277 0.5× 127 0.4× 103 0.5× 51 0.4× 93 0.8× 16 361
Hannah Snyder United States 13 354 0.7× 246 0.8× 63 0.3× 59 0.4× 78 0.7× 21 443

Countries citing papers authored by Emily Behar

Since Specialization
Citations

This map shows the geographic impact of Emily Behar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Behar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Behar more than expected).

Fields of papers citing papers by Emily Behar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Behar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Behar. The network helps show where Emily Behar may publish in the future.

Co-authorship network of co-authors of Emily Behar

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Behar. A scholar is included among the top collaborators of Emily Behar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Behar. Emily Behar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
2.
3.
Chang, Jamie, Emily Behar, & Phillip O. Coffin. (2019). Narratives of people who inject drugs on factors contributing to opioid overdose. International Journal of Drug Policy. 74. 26–32. 14 indexed citations
4.
Coffin, Phillip O., Glenn‐Milo Santos, Emily Behar, et al.. (2019). Randomized feasibility trial of directly observed versus unobserved hepatitis C treatment with ledipasvir-sofosbuvir among people who inject drugs. PLoS ONE. 14(6). e0217471–e0217471. 19 indexed citations
5.
Behar, Emily, et al.. (2019). Perceived Causes of Personal versus Witnessed Overdoses among People who Inject Opioids. Substance Use & Misuse. 54(12). 1929–1937. 3 indexed citations
6.
Rowe, Christopher, Eliza Wheeler, Eric Vittinghoff, et al.. (2018). Quantity fluctuations of illicitly used opioids and overdose risk. International Journal of Drug Policy. 58. 64–70. 7 indexed citations
7.
Hurstak, Emily, Christopher Rowe, Caitlin Turner, et al.. (2018). Using medical examiner case narratives to improve opioid overdose surveillance. International Journal of Drug Policy. 54. 35–42. 17 indexed citations
8.
Behar, Emily, et al.. (2018). Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review. Preventive Medicine. 114. 79–87. 51 indexed citations
9.
Behar, Emily, et al.. (2018). Acceptability of Naloxone Dispensing Among Pharmacists. Journal of Pharmacy Practice. 33(3). 247–254. 12 indexed citations
10.
Rowe, Chris, Emily Behar, Samuel L. Washington, et al.. (2017). Low-threshold extended-release naltrexone for high utilizers of public services with severe alcohol use disorder: A pilot study. Journal of Substance Abuse Treatment. 85. 109–115. 7 indexed citations
11.
Coffin, Phillip O., Glenn‐Milo Santos, Tim Matheson, et al.. (2017). Behavioral intervention to reduce opioid overdose among high-risk persons with opioid use disorder: A pilot randomized controlled trial. PLoS ONE. 12(10). e0183354–e0183354. 32 indexed citations
12.
Behar, Emily, et al.. (2017). Academic Detailing Pilot for Naloxone Prescribing Among Primary Care Providers in San Francisco.. PubMed. 49(2). 122–126. 25 indexed citations
13.
Behar, Emily, Christopher Rowe, Glenn‐Milo Santos, Sheigla Murphy, & Phillip O. Coffin. (2016). Primary Care Patient Experience with Naloxone Prescription. The Annals of Family Medicine. 14(5). 431–436. 31 indexed citations
14.
Behar, Emily, Christopher Rowe, Glenn‐Milo Santos, et al.. (2016). Acceptability of Naloxone Co-Prescription Among Primary Care Providers Treating Patients on Long-Term Opioid Therapy for Pain. Journal of General Internal Medicine. 32(3). 291–295. 27 indexed citations
15.
Coffin, Phillip O., Emily Behar, Christopher Rowe, et al.. (2016). Nonrandomized Intervention Study of Naloxone Coprescription for Primary Care Patients Receiving Long-Term Opioid Therapy for Pain. Annals of Internal Medicine. 165(4). 245–252. 136 indexed citations
16.
Rowe, Christopher, Eric Vittinghoff, Glenn‐Milo Santos, et al.. (2016). Performance Measures of Diagnostic Codes for Detecting Opioid Overdose in the Emergency Department. Academic Emergency Medicine. 24(4). 475–483. 87 indexed citations
17.
Rowe, Christopher, Glenn‐Milo Santos, Emily Behar, & Phillip O. Coffin. (2015). Correlates of overdose risk perception among illicit opioid users. Drug and Alcohol Dependence. 159. 234–239. 43 indexed citations
18.
Behar, Emily, Glenn‐Milo Santos, Eliza Wheeler, Christopher Rowe, & Phillip O. Coffin. (2014). Brief overdose education is sufficient for naloxone distribution to opioid users. Drug and Alcohol Dependence. 148. 209–212. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026